Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,150 | -3,217 | -948 | -597 | -2,635 |
| Depreciation Amortization | 1,162 | 220 | 47 | 1 | 35 |
| Accounts payable and accrued liabilities | 408 | 897 | 77 | 79 | 315 |
| Other Working Capital | 384 | 1,515 | 625 | 457 | 129 |
| Other Operating Activity | -383 | -500 | -42 | -56 | -134 |
| Operating Cash Flow | $-579 | $-1,085 | $-241 | $-116 | $-2,290 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 1,154 |
| PPE Investments | N/A | -3 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-3 | $N/A | $N/A | $1,154 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,250 | 1,500 | 250 | N/A | N/A |
| Debt Repayment | -195 | -250 | N/A | N/A | -23 |
| Common Stock Repurchased | N/A | -124 | N/A | N/A | N/A |
| Other Financing Activity | -25 | -119 | 5 | 35 | 0 |
| Financing Cash Flow | $1,030 | $1,007 | $255 | $35 | $-23 |
| Beginning Cash Position | 9 | 90 | 90 | 90 | 3,702 |
| End Cash Position | 460 | 9 | 104 | 9 | 2,543 |
| Net Cash Flow | $451 | $-81 | $14 | $-81 | $-1,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -579 | -1,085 | -241 | -116 | -2,290 |
| Capital Expenditure | N/A | -3 | 0 | 0 | N/A |
| Free Cash Flow | -579 | -1,088 | -241 | -116 | -2,290 |